JPRN-UMIN000003172招募中未知
Clinacal study on the intravesical instillation of dimethylsulfoxide (DMSO) for the patients with interstitial cystitis - DMSO for interstitial cystitis
Deparment of Urology, Medical Science, University of Fukui0 个研究点目标入组 30 人开始时间: 2010年2月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with cystitis other than interstitial cystitis or patients with bladder neoplasms
研究者
相似试验
尚未招募
2 期
Clinical study on the intravesical instillation of heparin, lidocain and bicarbonate for the patients with interstitial cystitisJPRN-UMIN000006387niversity of Tokushima30
进行中（未招募）
不适用
Pilot Study of the Intravesical Administration of EOquin Immediately Following Transurethral Resection in Patients with Superficial Bladder Cancer. - Not applicableBladder Cancer Stage 1 without Cancer in SituPatients will have transitional-cell carcinoma of the bladder, clinical TNM stage Ta or T1 and histologic grade G1 or G2 before transurethral resection.MedDRA version: 9Level: PTClassification code 10005009EUCTR2006-002372-18-NLSpectrum Pharmaceuticals, Inc.20
招募中
不适用
Prospective study of the efficacy of intravesical chemotherapy with THP against subsequent bladder cancer after nephrouretectomy (NUx) for upper urinary tract carcinoma (UUTC).rothelial carcinoma of upper urinary tractJPRN-UMIN000005767Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Science.100
招募中
3 期
Assessment of the therapeutic effect of intravesical Gemcitabine in patients with bladder cancer.IRCT20200402046915N1Shahid Beheshti University of Medical Sciences110
进行中（未招募）
不适用
ot availableTreatment of urinary tract infectionMedDRA version: 14.1Level: PTClassification code 10046571Term: Urinary tract infectionSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: HLTClassification code 10046577Term: Urinary tract infectionsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-004594-82-BGSchur Pharmazeutika GmbH & Co. KG